Role of Central Nervous System biomarkers in early discovery in drug development

Bharatbook added a new report on "Central Nervous System (CNS) Biomarkers: Technologies and Global Markets" which assess the global CNS biomarker market and make forecasts from 2010 to 2015.

Online PR News – 17-November-2010 – – Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Biomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, and predict treatment response. They have played, and will continue to play, an important role in drug R&D and in diagnostics. They are important tools for understanding disease mechanism, developing more effective treatments, and improving the quality of patient care. The discovery of biomarkers for CNS disorders has gained considerable interest within the pharmaceutical industry due to the many unmet needs in current treatments and diagnostics. ( )

Here we examine the role of CNS biomarkers in early discovery, in drug development, and for future diagnostics. We assess the global CNS biomarker market and make forecasts from 2010 to 2015. We further segment the market by application, technology (genomics, proteomics, and molecular imaging), and region. We discuss the different disease segments, describing gaps in treatment and limitations of current methods of diagnosis. The process of developing biomarkers from discovery to commercialization is discussed along with the forces in the industry that play an integral role, such as payers, providers, and suppliers. We also address the growth drivers and growth inhibitors that can affect CNS biomarker adoption.


To assess the various technologies used for CNS biomarker discovery and future diagnostics.
To understand the process of CNS biomarker development from discovery to commercialization and the path towards adoption.
To examine the regulatory landscape and government’s role.
To examine the unmet needs in diagnosis and treatment of various CNS disorders.
To determine current and future CNS biomarker markets.


This study was conducted to determine the current and future global demand for CNS biomarkers, taking into account various competitive forces, growth drivers, and growth barriers that are at play.

For more information kindly visit :

Related Reports

Therapeutic Drugs for Central Nervous System (CNS) Disorders: Technologies and Global Markets

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies


Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter: